Title |
Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease
|
---|---|
Published in |
Translational Neurodegeneration, December 2017
|
DOI | 10.1186/s40035-017-0104-6 |
Pubmed ID | |
Authors |
Daniel Kam Yin Chan, Ying Hua Xu, Luke Kar Man Chan, Nady Braidy, George D. Mellick |
Abstract |
In this mini-review, we summarize recent findings relating to the prion-like propagation of α-synuclein (α-syn) and the development of novel therapeutic strategies to target synucleinopathy in Parkinson's disease (PD). We link the Braak's staging hypothesis of PD with the recent evidence from in-vivo and in-vitro studies for the prion-like cell-to-cell propagation of α-syn (via exocytosis and endocytosis). The classical accumulation of aggregated α-syn in PD may result from an increased production or a failure in the mechanisms of clearance of α-syn. We discuss novel agents, currently in clinical trial for PD including the ones that impact the aggregation of α-syn and others that interfere with α-syn endocytosis as a means to target the progression of the disease. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 46 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 6 | 13% |
Student > Master | 6 | 13% |
Student > Ph. D. Student | 5 | 11% |
Student > Doctoral Student | 4 | 9% |
Researcher | 4 | 9% |
Other | 6 | 13% |
Unknown | 15 | 33% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 17% |
Medicine and Dentistry | 6 | 13% |
Agricultural and Biological Sciences | 4 | 9% |
Neuroscience | 4 | 9% |
Chemistry | 2 | 4% |
Other | 6 | 13% |
Unknown | 16 | 35% |